✦ LIBER ✦

Neurological recovery of a post operative liver failure patient after treatment with the hepatassist bioartificial liver support system

✍ Scribed by Stevens, Anthony C.; Salm, M. Jane; Johnson, Mark W.; Fair, Jeff H.; Gerber, David A.; Biomeical, Circe

Book ID: 122546912
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 165 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)81869-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First clinical application of a second g

First clinical application of a second generation HepatAssist bioartificial liver support system without charcoal associated with neurological recovery in a fulminant hepatic failure patient

✍ Arkadopoulos, Nikolaos; Alexandri, Maria; Poulakaki, Nikiforita; Papalois, Apost 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Treatment of patients with hepatic failu

Treatment of patients with hepatic failure: the difficult place of liver support systems

✍ Philippe Ichai; Didier Samuel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PGI13 ECONOMIC EVALUATION OF THE ARTIFIC

PGI13 ECONOMIC EVALUATION OF THE ARTIFICIAL LIVER SUPPORT SYSTEM MARS IN PATIENTS WITH ACUTE-ONCHRONIC LIVER FAILURE-FINAL RESULTS OF A CLINICAL COHORT TRIAL

✍ FP Hessel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Systemic hemodynamic effects of treatmen

Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial

✍ Lars E. Schmidt; Lars Peter Wang; Bent A. Hansen; Fin Stolze Larsen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Liver dysfunction as a predictor of outc

Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system

✍ Jonathan A. Yang; Tomoko S. Kato; Brittney P. Shulman; Hiroo Takayama; Maryjane 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 1018 KB

An interim analysis of a phase II/III pr

An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the hepatassist® bioartificial liver support system for the treatment of fulminant hepatic failure: Anthony C Stevens, Circe Biomed, Lexington, MA; R Busuttil, S Han, A Baquerizo, UCLA, Los Angeles, CA; J Fair, R Shrestha, M Johnson, UNC Sch of Medicine, Chapel Hill, NC; J Bloomer, B McGuire, Univ of Alabama, Birmingham, AL; P Rosenthal, N Ascher, C Freise, UCSF, San Francisco, CA; F Watanabe, Cedars Sinai Medical Ctr, Los Angeles, CA; X Rogiers, J Schulte am Esch, Univ Krankenhauf Eppendorf, Hamburg Germany; S Nyberg, R H Wiesner, Mayo Clinic, Rochester, MN; C Broelsch, M Malago, Universitatsklinikum Essen, Essen Germany; A Kribben, J Lerut, Cliniques Universitaires St Luc, Brussels Brussels Belgium; P Laterre, Cliniques Universitaires St Luc, Brussels Belgium; M Salizzoni, B Lavezzo, San Giovanni Battista di Torino, Turin Italy; R Brown, J Emond, S Lobritto, New York Presbyterian Hosp, New York, NY; B de Hemptinne, F Colardyn, E Hoste, Universitair Zeikenhaus Ghent, Ghent Belgium; E Fagan, Rush Presbyterian, Chicago, IL; L McChesney, Univ of Toledo, Toledo, OH; M Muraca, Univ di Padova, Padova Italy; A Mas Ordeig, J Salmeron, Hosp Clinic Provincial de Barcelona, Barcelona Spain; J Rabkin, Oregon Health Sciences Univ, Portland, OR; D Pratt, New England Medical Ctr, Boston, MA; M de la Mata, J Montero, J Pozo, Hosp Reina Sofia, Cordova Spain; H Metselaar, Univ Hosp Rotterdam, Rotterdam, The Netherlands, Rotterdam Netherlands; G Everson, Univ of Colorado, Denver, CO; Z Pitkin, C Mullon, B Solomon, Circe Biomed, Lexington, MA; A Demetriou, Cedars Sinai Medical Ctr, Los Angeles, CA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB